HEATHER BANKS: Open Payments
NPI 1023789658 · JACKSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 20 payments from 9 companies in 2025. Trend: 2023 $184 · 2024 $154 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $184 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $37 |
| Amgen Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| KYOWA KIRIN, INC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: QULIPTA, VRAYLAR, TRELEGY ELLIPTA, Cologuard Collection Kit, TEZSPIRE, FARXIGA, CRYSVITA, CAPLYTA.
Industry payments across KY — which companies pay providers there.
